Published online July 30, 2007
doi:10.1083/jcb.200701092
The Journal of Cell Biology, Vol. 178, No. 3, 425-436
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Lester et al.
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Robin D. Lester,
Minji Jo,
Valérie Montel,
Shinako Takimoto, and
Steven L. Gonias
Department of Pathology, University of California, San Diego, La Jolla, CA 92093
Correspondence to Steven L. Gonias sgonias{at}ucsd.edu
Hypoxia activates genetic programs that facilitate cell survival; however, in cancer, it may promote invasion and metastasis. In this study, we show that breast cancer cells cultured in 1.0% O2 demonstrate changes consistent with epithelial–mesenchymal transition (EMT). Snail translocates to the nucleus, and E-cadherin is lost from plasma membranes. Vimentin expression, cell migration, Matrigel invasion, and collagen remodeling are increased. Hypoxia-induced EMT is accompanied by increased expression of the urokinase-type plasminogen activator receptor (uPAR) and activation of cell signaling factors downstream of uPAR, including Akt and Rac1. Glycogen synthase kinase-3ß is phosphorylated, and Snail expression is increased. Hypoxia-induced EMT is blocked by uPAR gene silencing and mimicked by uPAR overexpression in normoxia. Antagonizing Rac1 or phosphatidylinositol 3-kinase also inhibits development of cellular properties associated with EMT in hypoxia. Breast cancer cells implanted on chick chorioallantoic membranes and treated with CoCl2, to model hypoxia, demonstrate increased dissemination. We conclude that in hypoxia, uPAR activates diverse cell signaling pathways that cooperatively induce EMT and may promote cancer metastasis.
R.D. Lester and M. Jo contributed equally to this paper.
Abbreviations used in this paper: CAM, chorioallantoic membrane; DN, dominant-negative; EMT, epithelial–mesenchymal transition; EpoR, erythropoietin receptor; ERK, extracellular signal-regulated kinase; GSK-3ß, glycogen synthase kinase-3ß; HIF, hypoxia-inducible factor; HPRT-1, hypoxanthine phosphoribosyltransferase 1; PI3K, phosphatidylinositol 3-kinase; qPCR, quantitative PCR; sh, short hairpin; uPA, urokinase-type plasminogen activator; uPAR, uPA receptor; VEGF, vascular endothelial growth factor.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
D'mello, V., Singh, S., Wu, Y., Birge, R. B.
(2009). The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells. J. Biol. Chem.
284: 17030-17038
[Abstract]
[Full Text]
-
Kim, Y., Kugler, M. C., Wei, Y., Kim, K. K., Li, X., Brumwell, A. N., Chapman, H. A.
(2009). Integrin {alpha}3{beta}1-dependent {beta}-catenin phosphorylation links epithelial Smad signaling to cell contacts. JCB
184: 309-322
[Abstract]
[Full Text]
-
Cannito, S., Novo, E., Compagnone, A., Valfre di Bonzo, L., Busletta, C., Zamara, E., Paternostro, C., Povero, D., Bandino, A., Bozzo, F., Cravanzola, C., Bravoco, V., Colombatto, S., Parola, M.
(2008). Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis
29: 2267-2278
[Abstract]
[Full Text]
-
Mazar, A. P.
(2008). Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy. Clin. Cancer Res.
14: 5649-5655
[Abstract]
[Full Text]
-
Smith, H. W., Marra, P., Marshall, C. J.
(2008). uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. JCB
182: 777-790
[Abstract]
[Full Text]
-
Gonias, S. L.
(2008). Urokinase: the identity crisis continues. Blood
112: 8-8
[Full Text]
-
Montel, V., Gaultier, A., Lester, R. D., Campana, W. M., Gonias, S. L.
(2007). The Low-Density Lipoprotein Receptor Related Protein Regulates Cancer Cell Survival and Metastasis Development. Cancer Res.
67: 9817-9824
[Abstract]
[Full Text]
-
Lester, R. D., Jo, M., Montel, V., Takimoto, S., Gonias, S. L.
(2007). uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. JEM
204: i21-i21
[Full Text]